BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Diagnosis
9 results:

  • 1. Stem gene expression in breast tumors during chemotherapy: Connection with the main clinical and morphological factors and the disease outcome.
    Ibragimova MK; Tsyganov MM; Deryusheva IV; Slonimskaya EM; Litviakov NV
    J Cancer Res Ther; 2022; 18(1):89-95. PubMed ID: 35381768
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Community-Based breast cancer Screening Using Digital breast Tomosynthesis Versus Digital Mammography: Comparison of Screening Performance and Tumor Characteristics.
    Regen-Tuero HC; Ram S; Gass JS; Lourenco AP
    AJR Am J Roentgenol; 2022 Feb; 218(2):249-257. PubMed ID: 34523954
    [No Abstract]    [Full Text] [Related]  

  • 3. Genetic and molecular mechanism for distinct clinical phenotypes conveyed by allelic truncating mutations implicated in FBN1.
    Lin M; Liu Z; Liu G; Zhao S; Li C; Chen W; Coban Akdemir Z; Lin J; Song X; Wang S; Xu Q; Zhao Y; Wang L; Zhang Y; Yan Z; Liu S; Liu J; Chen Y; Zuo Y; Yang X; Sun T; Yang XZ; Niu Y; Li X; You W; Qiu B; Ding C; Liu P; Zhang S; Carvalho CMB; Posey JE; Qiu G; ; Lupski JR; Wu Z; Zhang J; Wu N
    Mol Genet Genomic Med; 2020 Jan; 8(1):e1023. PubMed ID: 31774634
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Local Tumor Staging of breast cancer: Digital Mammography versus Digital Mammography Plus Tomosynthesis.
    Fontaine M; Tourasse C; Pages E; Laurent N; Laffargue G; Millet I; Molinari N; Taourel P
    Radiology; 2019 Jun; 291(3):594-603. PubMed ID: 30964425
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/smad2 axis.
    Wang F; Wu D; Chen J; Chen S; He F; Fu H; Wu Q; Liu S; Li X; Wang W
    Exp Cell Res; 2019 Feb; 375(1):1-10. PubMed ID: 30412716
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Y-box Binding Protein-1 Enhances Oncogenic Transforming Growth Factor β Signaling in breast cancer Cells
    Stope MB; Weiss M; Koensgen D; Popp SL; Joffroy C; Mustea A; Buck MB; Knabbe C
    Anticancer Res; 2017 Dec; 37(12):6745-6748. PubMed ID: 29187452
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Testes-specific protease 50 promotes cell proliferation via inhibiting activin signaling.
    Song ZB; Wu P; Ni JS; Liu T; Fan C; Bao YL; Wu Y; Sun LG; Yu CL; Huang YX; Li YX
    Oncogene; 2017 Oct; 36(43):5948-5957. PubMed ID: 28650473
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.
    Figueroa JD; Flanders KC; Garcia-Closas M; Anderson WF; Yang XR; Matsuno RK; Duggan MA; Pfeiffer RM; Ooshima A; Cornelison R; Gierach GL; Brinton LA; Lissowska J; Peplonska B; Wakefield LM; Sherman ME
    Breast Cancer Res Treat; 2010 Jun; 121(3):727-35. PubMed ID: 19937272
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Aberrant expression of E-cadherin in lobular carcinomas of the breast.
    Da Silva L; Parry S; Reid L; Keith P; Waddell N; Kossai M; Clarke C; Lakhani SR; Simpson PT
    Am J Surg Pathol; 2008 May; 32(5):773-83. PubMed ID: 18379416
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.